Skip to content

Safety and efficacy assessment of products on skin.

To assess the in vivo safety and efficacy of a skin care formulation in terms of reduction in dark spots on healthy female subjects - N/AP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037915
Enrollment
36
Registered
2021-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Bye Bye Pigmentation Cream: Take approximately 1 gm of the Product A on palm. Apply dot wise on whole face. Then gently massage using fingertips till the product is absorbed into the sk

Sponsors

AMVIGOR ORGANICS PVT LTD
Lead Sponsor
Cloud Wellness Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Indian Female subjects • Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) • Between 25 and 55 years of age. • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.)

Exclusion criteria

Exclusion criteria: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis

Design outcomes

Primary

MeasureTime frame
Safety & Efficacy assessment of productsTimepoint: Screening, T0 days, T14 days, T28 days, T56 days

Secondary

MeasureTime frame
N/APTimepoint: N/AP

Countries

India

Contacts

Public ContactMr Mohit Lalvani

Mascot Spincontrol India Pvt. Ltd.

raji@mascotspincontrol.in022-43349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026